BR9706041A - Inositolglicanos tendo ação semelhante à insulina. - Google Patents
Inositolglicanos tendo ação semelhante à insulina.Info
- Publication number
- BR9706041A BR9706041A BR9706041-0A BR9706041A BR9706041A BR 9706041 A BR9706041 A BR 9706041A BR 9706041 A BR9706041 A BR 9706041A BR 9706041 A BR9706041 A BR 9706041A
- Authority
- BR
- Brazil
- Prior art keywords
- insulin
- alkyl
- action
- inositolglycans
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/04—Disaccharides
Abstract
Patente de Invenção: <B>"INOSITOLGLICANOS TENDO AçãO SEMELHANTE à INSULINA"<D>. São descritos compostos da fórmula I onde A é o radical H-P(O)(OH)-, H-P(S)(OH)-, HO-P(S)(OH)-, HS-P(S)(OH)- alquila de (C~ 1~-C~ 4~) - P(O)(OH)-, alquila de (C~ 1~C~ 4~)- P(S)(OH)-, S(O)~ 2~(OR^ 1)-, S(O)(OR^ 1^)-, NH~ 2~ -C(O)-, R^ 1^R^ 2^N- C(O) - NH-, R^ 1^O-, SO~ 2~ -NH-, alquila de (C~ 1~-C~ 4~) - SO~ 2~- alquila de (C~ 1~-C~ 4~ - S(O) - ou R^ 1^ - S- , Z é 2 a 6 radicais de açúcar substituídos ou não substituídos e R é inositol substituído ou não substituído. Os compostos da fórmula I são adequados para o tratamento de diabete melito ou diabete não dependente de insulina.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19649350A DE19649350A1 (de) | 1996-11-28 | 1996-11-28 | Inositolglykane mit insulinartiger Wirkung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR9706041A true BR9706041A (pt) | 1999-11-23 |
| BR9706041C1 BR9706041C1 (pt) | 2000-06-06 |
Family
ID=7813041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9706041-0A BR9706041C1 (pt) | 1996-11-28 | 1997-11-27 | Inositolglicanos tendo ação semelhante à insulina. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6004938A (pt) |
| EP (1) | EP0845475B1 (pt) |
| JP (1) | JP4299378B2 (pt) |
| CN (1) | CN1136224C (pt) |
| AR (1) | AR018246A1 (pt) |
| AT (1) | ATE290541T1 (pt) |
| AU (1) | AU728637B2 (pt) |
| BR (1) | BR9706041C1 (pt) |
| CA (1) | CA2222103C (pt) |
| CZ (1) | CZ294886B6 (pt) |
| DE (2) | DE19649350A1 (pt) |
| DK (1) | DK0845475T3 (pt) |
| ES (1) | ES2237784T3 (pt) |
| HK (1) | HK1008786A1 (pt) |
| HU (1) | HUP9702242A3 (pt) |
| PL (1) | PL188604B1 (pt) |
| PT (1) | PT845475E (pt) |
| RU (1) | RU2178794C2 (pt) |
| TR (1) | TR199701432A2 (pt) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7312196B2 (en) * | 1997-01-08 | 2007-12-25 | Amylin Pharmaceuticals, Inc. | Formulations for amylin agonist peptides |
| GB9814039D0 (en) * | 1998-06-29 | 1998-08-26 | Univ London | Materials and methods relating to the prevention or treatment of ischaemia-reperfusion injury |
| US6939857B2 (en) | 2000-05-12 | 2005-09-06 | Rodaris Pharmaceuticals Limited | Compounds and their uses |
| AU6042601A (en) * | 2000-05-12 | 2001-11-20 | Rodaris Pharmaceuticals Limited | Compounds and their uses |
| US6953781B2 (en) | 2000-05-12 | 2005-10-11 | Rodaris Pharmaceuticals Limited | Compounds and their uses |
| EP1409501B1 (en) * | 2000-05-12 | 2008-03-05 | Rodaris Pharmaceuticals Limited | Inositol phosphoglycan derivatives and their medical uses |
| US6759390B2 (en) | 2000-05-12 | 2004-07-06 | Manuel Martin-Lomas | Compounds and their uses |
| US6716826B2 (en) | 2000-05-12 | 2004-04-06 | Rodaris Pharmaceuticals Limited | Compounds and their uses |
| CA2433857C (en) * | 2000-05-12 | 2012-07-31 | Rodaris Pharmaceuticals Limited | Inositol phosphoglycan derivatives and their medical uses |
| GB0015627D0 (en) * | 2000-06-26 | 2000-08-16 | Rademacher Group Limited | Phosphoglycan messengers and their medical uses |
| FR2828206B1 (fr) * | 2001-08-03 | 2004-09-24 | Centre Nat Rech Scient | Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire |
| WO2003092700A1 (en) | 2002-04-29 | 2003-11-13 | Gmp Oxycell, Inc. | Inositol pyrophosphates, and methods of use thereof |
| CA2491555C (en) * | 2002-07-10 | 2012-09-11 | Massachusetts Institute Of Technology | Solid-phase and solution-phase synthesis of glycosylphosphatidylinositol glycans |
| CN100369610C (zh) * | 2002-10-09 | 2008-02-20 | 中国药科大学 | 一种防治糖尿病的植物提取物及其制备方法与药物用途 |
| US20060106000A1 (en) * | 2004-07-06 | 2006-05-18 | Claude Nicolau | Use of inositol-tripyrophosphate in treating tumors and diseases |
| US20070135389A1 (en) * | 2004-07-06 | 2007-06-14 | Claude Nicolau | Tumor eradication by inositol-tripyrophosphate |
| US7745423B2 (en) * | 2004-07-06 | 2010-06-29 | NormOxys, Inc | Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin |
| FR2878850B1 (fr) * | 2004-12-02 | 2008-10-31 | Cis Bio Internat Sa | Derives de l'inositol-1-phosphate |
| EP2114414B1 (en) * | 2006-12-21 | 2013-11-06 | Trustees Of Tufts College | Synthetic lipophilic inositol glycans for treatment of cancer and glucose-metabolism disorders |
| CA2674048A1 (en) * | 2006-12-29 | 2008-07-10 | Normoxys, Inc. | Cyclitols and their derivatives and their therapeutic applications |
| JP2010526068A (ja) * | 2007-05-01 | 2010-07-29 | ノームオクシス インコーポレイテッド | エリスロポエチン補完または置換 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4446064A (en) * | 1980-12-19 | 1984-05-01 | The University Of Virginia Alumni Patents Foundation | Insulin mediator substance |
| DE3326473A1 (de) * | 1983-07-22 | 1985-01-31 | Hoechst Ag, 6230 Frankfurt | Pharmazeutisches mittel zur behandlung des diabetes mellitus |
| DE3326472A1 (de) * | 1983-07-22 | 1985-02-14 | Hoechst Ag, 6230 Frankfurt | Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus |
| US4906468A (en) * | 1986-04-11 | 1990-03-06 | The Rockefeller University | Insulin activity messengers, their antibodies, and thereof |
| YU66892A (sh) * | 1991-08-20 | 1995-10-24 | Hoechst Ag. | Fosfoinositolglikan - peptid sa delovanjem kao insulin |
| ATE184611T1 (de) * | 1991-11-29 | 1999-10-15 | Hoechst Ag | Peptide mit insulinartiger wirkung |
| JPH06293790A (ja) * | 1993-04-08 | 1994-10-21 | Kyowa Hakko Kogyo Co Ltd | 生理活性物質イノシトールグリカン |
| US5652221A (en) * | 1994-11-07 | 1997-07-29 | The University Of Virginia Patent Foundation | Method of treating defective glucose metabolism using synthetic insulin substances |
-
1996
- 1996-11-28 DE DE19649350A patent/DE19649350A1/de not_active Withdrawn
-
1997
- 1997-11-13 DK DK97119835T patent/DK0845475T3/da active
- 1997-11-13 AT AT97119835T patent/ATE290541T1/de not_active IP Right Cessation
- 1997-11-13 PT PT97119835T patent/PT845475E/pt unknown
- 1997-11-13 EP EP97119835A patent/EP0845475B1/de not_active Expired - Lifetime
- 1997-11-13 DE DE59712220T patent/DE59712220D1/de not_active Expired - Fee Related
- 1997-11-13 ES ES97119835T patent/ES2237784T3/es not_active Expired - Lifetime
- 1997-11-25 CA CA002222103A patent/CA2222103C/en not_active Expired - Fee Related
- 1997-11-26 CN CNB971229589A patent/CN1136224C/zh not_active Expired - Fee Related
- 1997-11-26 AU AU45382/97A patent/AU728637B2/en not_active Ceased
- 1997-11-26 TR TR97/01432A patent/TR199701432A2/xx unknown
- 1997-11-26 US US08/979,865 patent/US6004938A/en not_active Expired - Fee Related
- 1997-11-26 AR ARP970105573A patent/AR018246A1/es active IP Right Grant
- 1997-11-26 HU HU9702242A patent/HUP9702242A3/hu unknown
- 1997-11-27 JP JP32550897A patent/JP4299378B2/ja not_active Expired - Fee Related
- 1997-11-27 BR BR9706041-0A patent/BR9706041C1/pt active Search and Examination
- 1997-11-27 CZ CZ19973775A patent/CZ294886B6/cs not_active IP Right Cessation
- 1997-11-27 RU RU97120547/04A patent/RU2178794C2/ru not_active IP Right Cessation
- 1997-11-28 PL PL97323407A patent/PL188604B1/pl not_active IP Right Cessation
-
1998
- 1998-07-31 HK HK98109588A patent/HK1008786A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT845475E (pt) | 2005-06-30 |
| BR9706041C1 (pt) | 2000-06-06 |
| ES2237784T3 (es) | 2005-08-01 |
| DE19649350A1 (de) | 1998-06-04 |
| DK0845475T3 (da) | 2005-06-27 |
| HUP9702242A1 (hu) | 1998-12-28 |
| TR199701432A2 (xx) | 1998-06-22 |
| CZ294886B6 (cs) | 2005-04-13 |
| EP0845475A1 (de) | 1998-06-03 |
| US6004938A (en) | 1999-12-21 |
| HUP9702242A3 (en) | 1999-01-28 |
| PL323407A1 (en) | 1998-06-08 |
| HK1008786A1 (en) | 1999-05-21 |
| RU2178794C2 (ru) | 2002-01-27 |
| AU4538297A (en) | 1998-06-04 |
| CN1184112A (zh) | 1998-06-10 |
| DE59712220D1 (de) | 2005-04-14 |
| CA2222103C (en) | 2007-08-28 |
| JPH10158291A (ja) | 1998-06-16 |
| JP4299378B2 (ja) | 2009-07-22 |
| MX9709207A (es) | 1998-05-31 |
| CA2222103A1 (en) | 1998-05-28 |
| AU728637B2 (en) | 2001-01-11 |
| ATE290541T1 (de) | 2005-03-15 |
| AR018246A1 (es) | 2001-11-14 |
| CZ377597A3 (cs) | 1998-06-17 |
| HU9702242D0 (en) | 1998-03-02 |
| CN1136224C (zh) | 2004-01-28 |
| PL188604B1 (pl) | 2005-03-31 |
| EP0845475B1 (de) | 2005-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9706041C1 (pt) | Inositolglicanos tendo ação semelhante à insulina. | |
| BR9806060A (pt) | Composto, composição farmacêutica e processos para tratar um paciente sofrendo de um estado doentio, para inibir o fator xa, e, para inibir a formação de trombina. | |
| BR9809481A (pt) | Composto, processo para sua preparação, uso do mesmo, composição farmacêutica, e, processos para sua preparação, para efetuar a imunossupressão e para tratar ou reduzir o risco de uma doença obstrutiva reversìvel das vias aéreas em um paciente | |
| BR9813373A (pt) | Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente | |
| AR003938A1 (es) | Compuestos triciclicos de urea utiles para la inhibicion de la funcion de la proteina g y para tratamiento de enfermedades proteoliticas, composicionfarmaceutica, y el uso de los mismos para la preparacion de medicamentos. | |
| BR9713704A (pt) | Ceto-benzamida, uso da mesma, e, preparação de droga | |
| WO2004067550A3 (fr) | Nouvelle utilisation de la mifepristone et de ses derives comme modulateurs de la voie de signalisation des proteines hedgehog et ses applications | |
| CY1116988T1 (el) | Βητα-l-2'-δεοξυ-νουκλεοζιτες για την θεραπεια ηπατιτιδας β | |
| BR9708747A (pt) | Oxa diácidos e compostos relacionados para o tratamento de condições da pele | |
| KR950007868A (ko) | 항궤양제 및 헬리코박터·피롤리의 정착저해제 | |
| WO2000015205A3 (en) | Use of acetylcholinesterase inhibitors for the preparation of pharmaceutical compositions for the treatment of functional and/or organic pain syndromes | |
| AR012294A1 (es) | Derivados de sulfonamida, un procedimiento para su preparacion, composiciones farmaceuticas que los contienen, uso de dichos derivados para lapreparacion de un medicamento. | |
| BR9713921A (pt) | Composto, composição farmacêutica, processo para tógico capaz de ser modulado através da inibição do fator xa | |
| ES2128043T3 (es) | Uso de bis(amidinobencimidazoles) en la preparacion de un medicamento para inhibir la integrasa retroviral. | |
| BRPI0405657A (pt) | Método para o tratamento de insuficiência cardìaca grave e medicamento para o mesmo | |
| DK0506772T3 (da) | Farmaceutisk præparat indeholdende et phosphosukker | |
| NO931886D0 (no) | Anvendelse av aica ribocid-forbindelser for behandling/prevensjon av vevskader som skyldes nedsatt blodstroemning | |
| TR199701121T1 (xx) | Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri. | |
| BR9916845A (pt) | Compostos de (aminoiminometil ouaminometil)benzo-heteroarila substituìdos | |
| EP0821946A3 (de) | Stabile Lichtschutzzubereitungen mit einem Gehalt an grenzflächen aktive Glucosederivaten und wasserlöslichen UV-Filtersubstanzen | |
| ES2135722T3 (es) | 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina. | |
| BR9812120A (pt) | Derivados de 9h-1, 3-dioxolo/4, 5-h// 2,3 /benzodiazepina 8, composição farmacêutica eprocesso para sua preparação | |
| WO2002028880A8 (en) | Compounds useful for treating hypertriglyceridemia | |
| NO982229D0 (no) | Svovelholdige di-tert-butylfenol-forbindelser anvendbare som antiinflammatoriske midler | |
| ES2081783T1 (es) | Alcaloides procedentes de mappia foetida, uso de estos y formulaciones que los contienen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B03G | Publication of an application: publication cancelled [chapter 3.7 patent gazette] |
Free format text: REFERENTE A RPI 1507 DE 23/11/1999 |
|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 14A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE A 14A ANUIDADE. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |